ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1362 National Cancer Institute Html en Hot Flashes and Night Sweats (PDQ®)–Health Professional Version Expert-reviewed information summary about causes and treatment of hot flashes and night sweats in cancer patients.
hot flash scores0.45918
tamoxifen-induced hot flashes0.487401
Loprinzi CL0.545839
menopausal symptoms0.464059
Barton DL0.475444
nocturnal hot flashes0.494473
black cohosh0.488248
androgen deprivation therapy0.448869
clinical trial0.448391
breast cancer treatment0.460098
breast cancer patients0.474226
postmenopausal breast cancer0.456276
hot flashes merits0.487946
Natl Cancer Inst0.459556
breast cancer survivors0.509665
North Central Cancer0.472407
hot flash reduction0.458714
hot flashes0.905213
hormone replacement therapy0.476539
et al.0.506432
women0.50642
core body temperature0.45737
night sweats0.457026
study0.456946
stage breast cancer0.454333
hot flash studies0.449594
hot flushes0.465978
breast cancer diagnosis0.451556
postmenopausal hot flashes0.500892
breast cancer recurrence0.47207
hot flash management.0.448239
PUBMED Abstract0.549613
Cancer Res Treat0.462211
nighttime hot flashes0.501942
hot flash frequency0.50736
menopausal hot flashes0.487616
Cancer Treatment Group0.476248
hot flash management0.49365
postmenopausal women0.477394
breast cancer risk0.486953
Clin Oncol0.505954
receptor–positive breast cancer0.451466
breast cancer0.743246
randomized controlled trial0.545918
hot flash0.591793
healthy postmenopausal women0.454945
prostate cancer0.455636
placebo-controlled trial0.450402
Central Cancer Treatment0.476295
CLICK HERE
1375 National Cancer Institute Html en Cancer Screening Overview (PDQ®)–Health Professional Version Information about measuring the effectiveness of cancer screening tests and about weighing the strength of the evidence obtained from cancer screening research studies.
PDQ Screening0.435302
cancer antigen0.351044
cancer screening interventions0.511292
advanced-stage pancreatic cancer0.361147
cancer screening0.938139
lung cancer screening0.519031
new screening test0.500274
cancer prevention0.350991
Interval cancer events0.364348
new screening modality0.453389
IIIB–IV lung cancer0.361117
prostate screening0.417963
lung cancer rates0.355466
prostate cancer treatment0.3549
mammography screening0.457867
screening program0.415447
screening summaries0.435473
disease-specific mortality0.409334
cancer cases0.346604
whole-body screening technologies0.500642
lower cancer risk0.359738
interval cancer rates0.358328
colorectal cancer0.351483
routine cancer screening0.555956
recent screening0.436851
false-negative screening test0.511207
older screening modalities0.448481
breast cancer0.418358
cancer diagnosis0.374736
prostate cancer screening0.551218
actual cancer risk0.422669
cancer screening tests0.659235
randomized controlled trial0.36573
prostate cancer mortality.0.348853
false-positive screening results0.509129
screening center0.444606
fecal occult blood0.356414
higher cancer risk0.360321
cancer mortality.0.353113
decision making0.410621
all-cause mortality0.362129
breast cancer overdetection0.35093
routine screening mammographies0.474709
randomized clinical trials0.34952
Cancer Screening Trial0.566983
invasive diagnostic procedures0.355819
routine PSA screening0.472621
CLICK HERE
1452 National Cancer Institute Html en Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Health Professional Version Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.
smoking cessation strategy0.633721
smoking cessation rates0.605741
quit attempt0.552085
effective smoking cessation0.580922
gradual cessation group0.483049
abrupt cessation0.562882
prolonged validated smoking0.480554
lung cancer0.658405
tobacco cessation0.463262
smoking cessation pharmacotherapies0.597527
abrupt smoking cessation0.601297
pipe tobacco smoking0.505275
current smoking0.475722
gradual cessation arm0.465437
nicotine replacement therapy0.54532
randomized trial0.492165
Smoking cessation counseling0.609156
receptor partial agonist0.460896
area-level smoking prevalence0.513667
smoking reduction0.49426
smoking behavior0.469981
smoking cessation treatment0.588411
smoking prevalence data0.513642
tobacco products0.485537
abrupt cessation arm0.472163
smoking cessation0.926558
vs abrupt cessation0.475821
adult cigarette smoking0.474818
gradual cessation method0.466403
cigarette smoking cessation0.573293
cigarette smoking0.62168
smoking cessation pharmacotherapy0.595082
varenicline0.542592
tobacco smoking0.505702
smoking cessation rate.0.602815
gradual cessation0.501212
abrupt cessation group0.489713
nicotinic acetylcholine receptor0.464069
self-reported smoking abstinence0.502629
smoking abstinence0.574891
cigarette smoking prevalence0.566333
randomized controlled trial0.482431
6-month cessation rates0.474432
nicotine patch0.531368
smoking cessation intervention0.590903
usual smoking patterns0.480697
lung cancer mortality0.510576
varenicline group0.534998
CLICK HERE
1682 National Cancer Institute Html en Family Caregivers in Cancer: Roles and Challenges (PDQ®)–Health Professional Version Expert-reviewed information summary about the challenges faced by family caregivers of cancer patients. This summary focuses on typical caregiver roles and concerns, and helpful interventions for caregivers.
caregiver strain0.637562
caregiver self-efficacy0.583778
caregiver involvement0.610915
cancer care facility0.578352
palliative care consultation0.608288
caregiver knowledge0.586068
Hispanic caregivers0.676204
caregiver0.821035
Caregiver quality0.603509
white caregivers0.639176
health care providers0.59721
specialist-level palliative care0.56948
caregiver well-being0.592799
patient symptom care0.583377
culturally competent care0.564531
patients0.715455
cancer patients0.703941
Asian American caregivers0.689382
caregiver emotional health0.625075
secondary informal caregivers0.653486
caregiver burden0.63516
caregiver’s information0.595277
symptom management0.696609
orient caregivers0.633121
primary caregiver0.613245
caregiver portion0.581896
African American caregivers0.664952
caregiver needs0.592313
end-of-life care0.586635
family caregivers0.726566
study0.578902
problem-solving intervention0.564815
bereaved caregivers0.642182
palliative care0.6279
tailored caregiver interventions.0.613747
African American patients0.595756
caregivers0.977146
terminally ill patients0.564522
studies0.568233
empowers caregivers0.628512
caregiver roles0.620453
minority caregivers0.663649
emotional support0.572233
home care workers0.567134
Caregivers report0.630818
Caregiver assessment0.592589
family caregiver0.60516
cancer patient0.576832
difficult caregiver responsibilities0.601191
CLICK HERE
1790 National Cancer Institute Html es Trastornos del sueño (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca de las causas y manejo de los trastornos del sueño en las personas con cáncer.
menudo causa problemas0.738807
TCC ayuda0.533662
pequeño número0.542064
siguientes aspectos0.690699
siguientes elementos0.547894
leucemia linfocítica aguda0.539982
sudores nocturnos0.6269
siguientes cambios0.544948
menor número0.522208
Frecuencia respiratoria0.534403
fase monr0.549571
salud afectarán0.52618
National Cancer Institute0.522679
sueño mejora0.68532
siguientes riesgos0.520223
sueño mor0.930755
Instituto Nacional0.543079
siguientes problemas0.588617
siguientes funciones0.571878
Physician Data Query0.591028
fase mor0.552867
PDQ Trastornos0.547079
auto hipnosis0.530427
numerosas razones0.546303
solo relajarme0.534672
CLICK HERE
2105 National Cancer Institute Html es Exámenes de detección del cáncer de endometrio (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de endometrio.
Surgical Adjuvant Breast0.318516
Obstet Gynecol0.462808
endometrial neoplasia0.330318
endometrial carcinoma0.35462
mujeres asintomáticas conducirán0.327753
endometrial biopsy0.375747
Society Cancer Detection0.324775
Sin embargo0.322994
American Cancer Society0.532275
Barakat RR0.322448
postmenopausal estrogen0.311047
Hereditary nonpolyposis colon0.316803
Cancer Society Guidelines0.326353
mutation analysis0.309345
CA Cancer0.344524
ecografía transvaginal0.32543
Instituto Nacional0.316776
PDQ Exámenes0.310268
Natl Cancer Inst0.409601
Vasen HF0.314679
Bowel Project P-10.314149
Survival analysis0.309166
endometrial thickness0.328405
Gynecol Oncol0.319248
patients with0.312917
endometrial cancer0.986652
Endometrial morphology0.328059
Genetics Studies Consortium0.313592
Cancer Facts0.328027
Cancer risk0.385512
with endometrial biopsy0.334209
mutation carriers0.308983
Cancer Survival Study0.330775
hereditary nonpolyposis0.373835
National Cancer Institute0.323419
endometrial biopsy specimens0.329768
replacement therapy0.315579
postmenopausal women0.352328
Clin Oncol0.321066
Gynaecol Obstet0.310774
PDQ Genetics0.309874
mujeres portadoras0.322212
adjuvant breast0.320298
ecografía endovaginal0.333573
endometrial abnormalities0.37706
National Surgical Adjuvant0.314342
Ultrasound Obstet Gynecol0.310185
mujeres morirán0.321645
Mecklin JP0.317214
CLICK HERE
3523 National Cancer Institute Html es Estudio NCI-MATCH (Análisis Molecular para Selección de Tratamientos) Información sobre el estudio del NCI: Análisis Molecular para Selección de Tratamientos (NCI-MATCH), en el cual los investigadores examinarán tejidos de tumor de pacientes con tumores sólidos y linfomas avanzados que han dejado de responder al tratamiento.
Tumor Profiling0.554625
estudio match0.941659
Investigación Oncológica0.6022
MD Anderson0.61416
Memorial Sloan-Kettering Cancer0.578519
Clinical Trials0.539697
posibles participantes0.607033
C2 MET0.546519
Life Sciences0.627896
laboratorios foundation medicine0.56991
Foundation Medicine0.623082
Memorial Sloan-Kettering identificarán0.577406
estudio comet0.807536
Grupo Cambio0.537516
met amp crizotinib0.576245
como los costos0.539059
seguro médico0.533808
Cancer Center0.605302
MD Anderson Cancer0.572606
tratamiento inscribirán0.618222
sk crizotinib0.541473
cabo estudios0.534561
Caris Life Sciences0.579205
Investigación Oncológica ECOG-ACRIN0.571301
Memorial Sloan-Kettering0.625566
egfr mut afatinib0.573282
NRG Oncology Group0.568484
Iniciativa de Medicina0.538366
Life Sciences identificarán0.57351
CLICK HERE
4329 National Cancer Institute Html en Cancer Screening A summary of the benefits and possible harms of cancer screening tests.
time symptoms0.320649
abnormal tissue0.346264
False-negative test results0.440391
screening tests0.953871
false reassurance0.328265
potential harms0.743558
different cancer screening0.573019
medical care0.312433
people0.200595
Early detection0.319119
additional tests0.299571
health problems0.324983
doctors0.208104
False-positive test results0.450006
cancer0.861445
CLICK HERE
14600 National Cancer Institute Html es Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.
Natl Acad Sci0.324634
anomalías vasculares retinianas0.33309
hemangiomas is directly0.365854
lesiones benignas0.319493
Infants With Infantile0.316042
lesiones precursoras0.322133
frecuencia cardíaca0.363288
cells from hemangiomas0.365897
Denise Adams0.34719
Ampliar Figura0.334799
hemangiomas perioculares subcutáneos0.383239
propranolol quizás0.334782
Prospective study0.315057
capillary hemangioma0.369091
International Society0.348608
vasculares hepáticos benignos0.326723
tumores vasculares benignos0.402681
Léauté-Labrèze C0.314686
evaluación cardíaca0.323474
angiofibromas nasofaríngeos0.342724
síndrome phace0.577507
angiofibroma nasofaríngeo0.314735
anomalías renales0.316886
Children With Infantile0.315749
oral propranolol0.362065
Clin Invest0.327186
hemangiomas congénitos0.761656
endothelial cells0.315693
hemangiomas cutáneos0.372477
Arch Dermatol0.329954
Cuadro clínico0.393896
Proc Natl Acad0.325302
infantile hemangiomas0.938164
With Infantile Hemangioma0.438965
Nadolol Versus Propranolol0.33549
vías respiratorias0.521847
granuloma piógeno0.329351
Vascular Anomalies Classification0.319289
insuficiencia cardíaca transitoria0.335633
antecedentes familiares0.32937
hemangioma cutáneo congénito0.383839
Complicated Vascular Anomalies0.316136
Benigno Hemangioma0.393265
Drolet BA0.324986
lesiones cutáneas0.338858
clasificación issva0.316546
Blei F0.314967
hemangioma epitelioide0.552561
Hoeger P0.315823
CLICK HERE
15802 National Cancer Institute Html null About the Blue Ribbon Panel Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.